Profile
Dushyant B.
Varshney's former jobs include being the Head of Manufacturing, Science & Technology at Pfizer Inc., the Global Head of Technical Services & Operations at Jubilant Pharma Ltd., and the Global Head of Manufacturing, Science & Technology at Kite Pharma, Inc. He also served as the Chief Technology Officer & Executive VP at Arcturus Therapeutics Holdings, Inc. from 2021 to 2023.
Dr. Varshney's education history includes a doctorate degree from the University of Iowa, an undergraduate degree from the University of Pune, and a graduate degree from the Institute of Chemical Technology.
Former positions of Dushyant Varshney
| Companies | Position | End |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 2023-11-30 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | - |
Jubilant Pharma Ltd.
 Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Jubilant Pharma Ltd. manufactures pharmaceutical products. Its products include solid dosage formulations, radiopharmaceuticals and allergy therapy products. The firm provides contract manufacturing services. The company is headquartered in Singapore. | Chief Tech/Sci/R&D Officer | - |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | - |
Training of Dushyant Varshney
| University of Iowa | Doctorate Degree |
| University of Pune | Undergraduate Degree |
| Institute of Chemical Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Jubilant Pharma Ltd.
Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Jubilant Pharma Ltd. manufactures pharmaceutical products. Its products include solid dosage formulations, radiopharmaceuticals and allergy therapy products. The firm provides contract manufacturing services. The company is headquartered in Singapore. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Dushyant Varshney
